Rafarma pharmaceutical updates: registration of Rafarma microspheres in South Korea

July 4, 2024

Sheridan, Wyoming, USA, July 04, 2024 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals (OTC: RAFA) – Rafarma Pharmaceuticals is pleased to announce its participation in the scientific conference on radioembolization using Yttrium 90 microspheres for the treatment of cancer at Severance Hospital in Seoul, South Korea. It is one of the largest university hospitals in South Korea and is of strategic importance to the country.

Read more at globenewswire.com

Related news for (RAFA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.